This preparation is primarily used to address deficiencies of the essential nutrient Vitamin C (L-Ascorbate), which is considered relevant for systemic health. The medicine is applied in addressing established Vitamin C depletion, which includes managing deficiency-driven symptoms and addressing conditions up to the severe clinical presentation of scurvy.

The core therapeutic domains are used for managing Vitamin C deficiency, providing supportive relief during temporary states of generalized weakness (asthenia), and is relevant for easing symptoms related to systemic imbalance, such as non-specific fatigue. This use is relevant for managing symptoms that interfere with daily functioning, such as lassitude and malaise, and assists with maintaining functional stability when managing temporary physiological imbalance during periods like seasonal change or overwork.

“The primary purpose is to address nutritional deficiencies and provide support during periods of temporary physiological strain.”

This preparation provides the essential micronutrient required to address symptoms of depletion, and contributes to the maintenance of normal systemic function.

---

Quick Fact: Relief for Non-Specific Fatigue The medicine is commonly used to help with symptoms related to systemic imbalance, such as passing states of tiredness and weakness that are not linked to a specific underlying disease.

Regulatory References

1. NIH MedlinePlus overview of Ascorbic Acid

The eligibility for using Vitamine C UPSA is strictly defined by regulatory authorities based on age, specific medical conditions, and physiological status.

Regulatory Eligibility Classifications

Classification	Documented Population Restriction
Absolute Contraindication	Patients with known hypersensitivity to the active substances (Ascorbic Acid or Sodium Ascorbate) or excipients. Patients with a history of kidney stones (oxalate urolithiasis).
Age Restriction	The 1, g formulation is reserved for adults and children over 15 years; it is not recommended for children under 15 for the stated indication.
Use with Caution	Required for patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency due to the potential risk of haemolysis (destruction of red blood cells), especially with high doses. Also necessary for individuals with iron storage disorders (e.g., haemochromatosis), as the medicine enhances iron absorption.
Physiological Status Restriction	Use during breastfeeding is to be avoided. During pregnancy, use should only be considered if clearly necessary, with high doses restricted due to officially unknown effects on the fetus.

These official statements delineate who may or must not use the medicine. The primary exclusion criteria are applied based on a patient's hypersensitivity and renal condition, while age limits use of the high-dose product for temporary fatigue. Caution is also formally required for those with specific metabolic and hematologic predispositions.

Interactions with other medicines and products

The interaction profile of Ascorbic Acid, the active component of Vitamine C UPSA, is defined by its ability to modify drug exposure and pharmacodynamic action, as documented in regulatory information. Strict restrictions apply to co-administration with certain products.

Documented Interactions and Restrictions

Interacting Substance	Official Interaction Outcome and Constraint
Deferoxamine	Co-administration may lead to cardiac impairment, particularly in patients with existing cardiac issues. Initiation of Ascorbic Acid must be delayed until after the first month of Deferoxamine therapy.
Aluminum-containing Antacids	Ascorbic Acid increases the absorption of aluminum. Administration must be separated by at least 2 hours before or 4 hours after the antacid dose.
Anticoagulants (e.g., Warfarin)	Regulatory documents note a potential for a diminished anticoagulant effect (Warfarin resistance).
Oral Contraceptives	Co-administration may increase the plasma concentration of estrogen components.
Basic Drugs (e.g., Amphetamines)	Ascorbic Acid causes urine acidification, increasing the renal excretion of basic medicines and potentially decreasing their serum levels.
Select Antibiotics	The activity of certain antibiotics, including Erythromycin and Kanamycin, may be decreased.

Population-Specific Interaction Notes

Official labeling specifies increased risks for certain populations. Patients with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency are noted to have a higher risk for severe hemolysis following administration. Individuals with existing renal disease are noted to have an increased risk for oxalate nephropathy and are more susceptible to aluminum toxicity when co-administering aluminum-containing antacids.

The mechanism of action for Ascorbic Acid (Vitamin C) is defined by its role as a primary electron donor, contributing to the maintenance of cellular redox balance and supporting essential enzymatic reactions. Its physiological effects are not mediated by receptors but by sustaining core biochemical functions.

Cofactor Role in Neurotransmitter and Collagen Synthesis

The active component acts as a vital cofactor by maintaining enzyme-bound metal ions ( Fe^2+ and Cu^+) in their reduced state. This action is critical for specific hydroxylase enzymes required for the post-translational maturation of collagen and for the biosynthesis of the central neurotransmitter norepinephrine from dopamine. This enzymatic support influences the synthesis required for tissue structural stability (e.g., blood vessels) and contributes to the regulation of central nervous system drive and supporting cellular energy pathways.

️ Systemic Modulation of Cellular Redox Balance

Ascorbate functions as a water-soluble antioxidant, rapidly neutralizing harmful Reactive Oxygen Species (ROS) and free radicals within the cell's aqueous environment. This continuous scavenging activity is fundamental to preserving the integrity of lipids, proteins, and genetic material. Modulating the cellular redox status assists in maintaining cellular function under conditions of increased metabolic activity or oxidative challenge.

Formulation and Mechanistic Constraint

The active ingredients yield the identical molecule, the Ascorbate anion, meaning their mechanism of action is singular. This mechanism is subject to a physiological constraint due to the saturation of dedicated transport proteins (SVCTs), meaning beyond a certain threshold, the body cannot proportionally increase the cofactor activity in its target pathways.

The administration of Vitamine C UPSA follows a specific protocol based on the medicine's dosage form and strength. The preparation is strictly administered via the oral route, available primarily as a 1000 mg effervescent tablet or a 500 mg chewable tablet. The use of this preparation is reserved for adults and children over 15 years of age.

The standard daily dosing pattern for the 1000 mg effervescent formulation is one tablet per day. For the 500 mg chewable formulation, the regimen is one to two tablets per day. The maximum permissible dose is 1 gram (1000 mg) per 24 hours, a limit essential to maintain, given that the absorption of oral Ascorbic Acid decreases significantly when doses exceed 1 gram.

Specific preparation steps are required for ingestion. The effervescent tablet must be dissolved completely in half a glass of water prior to consumption, while the chewable tablet must be masticated before swallowing. The dose is preferably taken in the morning, during or after a meal, and it is recommended to avoid administration at the end of the day. For its designated use in temporary states of fatigue, the maximum duration of continuous treatment is limited to one month.

Research Evidence / Overview of Studies for Vitamine C UPSA

Evidence for Use in Correcting Vitamin C Deficiency

Research has explored the role of Ascorbic Acid as an essential nutrient in the context of severe lack of the vitamin, known as scurvy. Evidence for this use is drawn from extensive observational studies and historical case series. These studies examined how symptoms related to physical discomfort evolved in individuals with confirmed deficiency.

Research describes a consistent pattern where Ascorbic Acid administration was associated with changes in measured plasma and leukocyte levels of the vitamin. The reports consistently described a pattern where changes in clinical signs were observed over short, defined intervals. Since the fundamental need for Vitamin C to prevent deficiency is well-understood, research gaps are minimal for this primary purpose.

---

Evidence for Use in Temporary Non-Specific Fatigue

This block will describe the existing clinical research base where Ascorbic Acid administration was evaluated in the context of temporary tiredness, focusing on Randomized Controlled Trials (RCTs). Studies explored Ascorbic Acid administration in trials assessing short-term or episodic symptom patterns, such as temporary non-specific fatigue. These studies primarily focused on healthy working adults and compared the effects of Vitamin C against a placebo.

Findings were mixed across studies examining outcomes related to systemic imbalance, such as lassitude. Some trials reported that subjective fatigue scores changed during the study period, while others reported no significant variation. Research suggests that changes measured during the study period may be linked to a person's pre-existing nutritional status.

---

What is Still Uncertain About Ascorbic Acid Research

The research summarizes what is known and what is still uncertain regarding the research landscape. For the indication of temporary fatigue, findings were mixed, and inconsistency in the research remains. A key research limitation is that many of the findings indicating change were associated with studies that used intravenous administration, a different route than the oral tablet form. Furthermore, long-term effects are not fully established, and there is limited information for long-term outcomes.

Key Studies & References

1. Base de Données Publique des Médicaments (French public database for regulatory classification and formulation)

Common questions about Vitamine C UPSA (FAQ)

Q: Is Vitamine C UPSA the same as other vitamin C supplements I can buy?

According to official product information, products containing Ascorbic Acid may be classified differently based on the country and their specific intended use. Vitamine C UPSA is formally designated as a medicine (pharmacological tonic) in some jurisdictions. This classification differentiates it from general, non-regulated dietary supplements.

Q: Why does Vitamine C UPSA sometimes cause stomach issues?

Gastrointestinal (stomach and bowel) issues have been reported as potential adverse effects of Ascorbic Acid. Official information states that symptoms such as diarrhea, heartburn, or nausea are more commonly associated with consuming doses above 1,000 mg per day.

Q: Is it normal to feel a mild burning sensation after taking the fizzy tablet?

Effervescent tablets contain ingredients, such as citric acid, that create the fizzing action upon dissolving. In some cases, gastrointestinal symptoms like heartburn have been reported as adverse effects, which may present as a mild burning sensation.

Q: Is a headache a known side effect of Vitamine C UPSA?

Regulatory documents note that headache has been reported as a potential adverse effect of Ascorbic Acid. This symptom is generally associated with the use of higher doses of the medicine.

Q: Is the color or taste of the dissolved tablet supposed to change over time?

Official guidelines advise that the dissolved effervescent tablet should be consumed immediately after preparation to ensure product stability. Although some formulations have a limited period of stability, the preparation is designed for prompt use after reconstitution.

Q: Can children or adolescents use Vitamine C UPSA?

Official documents state that the 1 g formulation is reserved for adults and children over 15 years of age for the stated purpose. Eligibility for use is determined by age restrictions outlined in the regulatory label. Furthermore, authoritative health organizations publish specific Recommended Dietary Allowances (RDA) and Upper Limits (UL) for Ascorbic Acid that vary depending on a person's age.

Q: How long does the effect of Vitamine C UPSA typically last in the body?

Ascorbic Acid is a water-soluble vitamin, which means the body does not store it in significant amounts, requiring consistent external intake. Pharmacokinetic studies examine how the concentration of the vitamin in the blood changes over time following administration.

Q: Why do people mention taking Vitamine C UPSA for fatigue?

The medicine is officially used to provide support during temporary states of non-specific fatigue. This is based on the recognized physiological function of vitamin C, which official product labeling states contributes to normal energy metabolism.

Q: Does Vitamine C UPSA interact with common cold medications?

Regulatory documents for some Ascorbic Acid products state that there are no known clinically significant interactions with other medicines. It is important that patients inform their healthcare provider about all medicines they are currently taking.

Q: Is there a high risk of drug-drug interactions with Vitamine C UPSA?

Official drug reference resources indicate that Ascorbic Acid has no known severe interactions with other medications. However, regulatory information does list a number of moderate and mild interactions that are important to be aware of.

Q: Are there any long-term research findings about the consistent use of Vitamine C UPSA?

The official summary of research evidence addresses the use of the medicine, noting that the long-term effects are not fully established. As a result, there is limited information available concerning outcomes from consistent long-term use.

Q: Can someone who is vegetarian or vegan use the Vitamine C UPSA tablets?

The active ingredients are Ascorbic Acid and Sodium Ascorbate. The determination of whether the product is suitable for vegetarian or vegan diets depends on the specific non-active ingredients, or excipients, used in the tablet, which are listed in the full product documentation.

Q: Does Vitamine C UPSA interact with common pain relievers?

Official interaction lists note that certain common pain relievers, such as aspirin (Acetylsalicylic acid), are listed as having a minor interaction with Ascorbic Acid.

Q: What types of heart or circulatory conditions might restrict someone from using Vitamine C UPSA?

The effervescent formulation contains sodium, which requires caution for patients adhering to a sodium-restricted diet. This includes individuals with conditions like congestive heart failure or certain forms of hypertension.

Q: Why is high-dose vitamin C sometimes mentioned in the context of certain conditions?

Official regulatory documentation strictly defines the medicine’s approved uses and sets a maximum permissible dose for those uses. Discussions concerning high doses for purposes other than the stated indications are outside the scope of the medicine's regulatory approval.

Q: Are there any known interactions between Vitamine C UPSA and herbal supplements?

Regulatory interaction lists focus primarily on prescription and over-the-counter medicines. A specific entry mentions rose hips as having a potential minor interaction. It is important to disclose the use of any herbal supplements to a healthcare professional.

Q: Is there a warning about using Vitamine C UPSA with antacids?

There is an official warning concerning the use of the medicine with aluminum-containing antacids. Ascorbic Acid can increase the absorption of aluminum, and official instructions recommend separating the administration by at least 2 hours before or 4 hours after the antacid dose.

Q: Why do people confuse the purpose of Vitamine C UPSA with treating a cold?

The medicine is officially indicated for the correction of Vitamin C deficiency and temporary fatigue support. Historical context shows that the role of vitamin C in relation to the common cold has been the subject of conflicting evidence across clinical studies, a topic that is often noted in research summaries.

Q: Is it possible to become dependent on Vitamine C UPSA?

Official warnings note that chronic use of high doses of Ascorbic Acid can lead to an increased metabolism of the substance. If dosage is suddenly reduced, this change in metabolism may be associated with symptoms resembling a deficiency.

Q: Does taking Vitamine C UPSA at the same time as iron supplements cause any issues?

Ascorbic Acid is known to enhance the body’s absorption of nonheme iron. This enhancing effect is why official cautions exist for individuals with iron storage disorders, such as haemochromatosis, where high doses could increase the risk of iron toxicity.

Q: Are there any known issues with taking Vitamine C UPSA and diabetes medication?

Official safety information notes that high doses of Ascorbic Acid can interfere with certain laboratory measurements. This may lead to falsely low or high readings for tests that measure glucose in the blood and urine. For accuracy, medical staff should be informed of the use of high-dose Ascorbic Acid.

Official Storage and Disposal Profile

The storage of Vitamine C UPSA (1000 mg effervescent tablets) is governed by official constraints intended to maintain the product's stability and efficacy.

Storage Condition Type
Protect from Moisture and Keep Tightly Closed (Ambient storage, typically leq 25 C or 30 C for stability).

• Handling Requirements: The container must be kept carefully closed to protect the hygroscopic tablets from moisture and must remain in the original packaging. Although the product's label may state no special storage precautions, similar regulatory documents limit storage temperature to not exceeding 25 C.
• Child-Protection: The medicine must be kept out of the sight and reach of children.
• Disposal Instructions: The product must not be used after the expiration date and must not be discarded into the wastewater system or household waste. Unused medicine must be returned to a pharmacist for disposal according to local official regulations.